RU2017125963A - Способ повышения устойчивости композиции, содержащей омега-6 полиненасыщенные жирные кислоты - Google Patents
Способ повышения устойчивости композиции, содержащей омега-6 полиненасыщенные жирные кислоты Download PDFInfo
- Publication number
- RU2017125963A RU2017125963A RU2017125963A RU2017125963A RU2017125963A RU 2017125963 A RU2017125963 A RU 2017125963A RU 2017125963 A RU2017125963 A RU 2017125963A RU 2017125963 A RU2017125963 A RU 2017125963A RU 2017125963 A RU2017125963 A RU 2017125963A
- Authority
- RU
- Russia
- Prior art keywords
- composition
- lysine
- polyunsaturated fatty
- fatty acids
- omega
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims 19
- 235000020665 omega-6 fatty acid Nutrition 0.000 title claims 8
- 238000000034 method Methods 0.000 title claims 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 10
- 239000004472 Lysine Substances 0.000 claims 8
- 238000004519 manufacturing process Methods 0.000 claims 3
- 150000001450 anions Chemical class 0.000 claims 2
- 150000001768 cations Chemical class 0.000 claims 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims 2
- 229930195729 fatty acid Natural products 0.000 claims 2
- 239000000194 fatty acid Substances 0.000 claims 2
- 150000003839 salts Chemical group 0.000 claims 2
- 230000001476 alcoholic effect Effects 0.000 claims 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 claims 1
- -1 fatty acid esters Chemical class 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 claims 1
- 230000003647 oxidation Effects 0.000 claims 1
- 238000007254 oxidation reaction Methods 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 239000008247 solid mixture Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 238000001694 spray drying Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B5/00—Preserving by using additives, e.g. anti-oxidants
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B5/00—Preserving by using additives, e.g. anti-oxidants
- C11B5/0021—Preserving by using additives, e.g. anti-oxidants containing oxygen
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B5/00—Preserving by using additives, e.g. anti-oxidants
- C11B5/0085—Substances of natural origin of unknown constitution, f.i. plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/186—Fatty acids
- A23V2250/1882—Polyunsaturated fatty acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Botany (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Anesthesiology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Claims (11)
1. Способ повышения устойчивости к окислению композиции, содержащей омега-6 полиненасыщенные жирные кислоты, включающий следующие стадии:
(i) обеспечение исходной композиции, содержащей по меньшей мере один компонент, представляющий собой омега-6 полиненасыщенную жирную кислоту;
(ii) обеспечение композиции на основе лизина;
(iii) смешивание водных, водно-спиртовых или спиртовых растворов исходной композиции и композиции на основе лизина и затем подвергание полученной в результате смеси воздействию условий высушивания распылением с образованием, таким образом, композиции в виде твердого продукта, содержащей по меньшей мере одну соль, образованную катионом, полученным из лизина, и анионом, полученным из омега-6 полиненасыщенной жирной кислоты; при этом композиция в виде продукта характеризуется содержанием растворителя SC, выбранным из следующего: SC < 5 вес. %, SC < 3 вес. %, SC < 1 вес. %, SC < 0,5 вес. %.
2. Способ по п. 1, где композицию на основе лизина на стадии (ii) обеспечивают таким образом, что отношение R = n(ca)/n(lys) количества функциональных групп карбоновой кислоты n(ca) в исходной композиции, обеспеченной на стадии (i), к количеству лизина n(lys) в композиции на основе лизина, обеспеченной на стадии (ii), находится в диапазоне, выбранном из 0,9 < R < 1,1, 0,95 < R < 1,05, 0,98 < R < 1,02.
3. Способ по п. 2, где исходная композиция, обеспеченная на стадии (i), содержит не более x(fe) вес. % сложных эфиров жирных кислот, где x(fe) выбран из 5, 3, 2, 1, 0,3, 0.
4. Способ по п. 3, где исходную композицию на стадии (i) и композицию на основе лизина на стадии (ii) обеспечивают таким образом, что по меньшей мере sp вес. % композиции в виде продукта состоит из одной или более солей, образованных катионами, полученными из лизина, и анионами, полученными из одной или более омега-6 полиненасыщенных жирных кислот и других встречающихся в природе жирных кислот, при этом sp выбран из 90, 95, 97, 98, 99, 100.
5. Композиция, получаемая с помощью способа по любому из пп. 1-4.
6. Применение композиции по п. 5 для изготовления пищевых продуктов, содержащих омега-6 полиненасыщенные жирные кислоты.
7. Применение композиции по п. 5 для изготовления питательных продуктов, содержащих омега-6 полиненасыщенные жирные кислоты.
8. Применение композиции по п. 5 для изготовления фармацевтических продуктов, содержащих омега-6 полиненасыщенные жирные кислоты.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14199976.3 | 2014-12-23 | ||
EP14199976 | 2014-12-23 | ||
PCT/EP2015/080293 WO2016102316A1 (en) | 2014-12-23 | 2015-12-17 | Process for increasing the stability of a composition comprising polyunsaturated omega-6 fatty acids |
Publications (3)
Publication Number | Publication Date |
---|---|
RU2017125963A true RU2017125963A (ru) | 2019-01-24 |
RU2017125963A3 RU2017125963A3 (ru) | 2019-06-18 |
RU2706072C2 RU2706072C2 (ru) | 2019-11-13 |
Family
ID=52344990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2017125963A RU2706072C2 (ru) | 2014-12-23 | 2015-12-17 | Способ повышения устойчивости композиции, содержащей омега-6 полиненасыщенные жирные кислоты |
Country Status (25)
Country | Link |
---|---|
US (1) | US20170367394A1 (ru) |
EP (1) | EP3236783B1 (ru) |
JP (1) | JP6714000B2 (ru) |
KR (1) | KR20170094789A (ru) |
CN (1) | CN107105693B (ru) |
AU (1) | AU2015371457B2 (ru) |
BR (1) | BR112017013445B1 (ru) |
CA (1) | CA2969157A1 (ru) |
CL (1) | CL2017001613A1 (ru) |
CO (1) | CO2017005849A2 (ru) |
DK (1) | DK3236783T3 (ru) |
ES (1) | ES2776393T3 (ru) |
IL (1) | IL252482B (ru) |
MX (1) | MX2017008274A (ru) |
MY (1) | MY190506A (ru) |
NZ (1) | NZ732380A (ru) |
PE (1) | PE20171082A1 (ru) |
PH (1) | PH12017501144A1 (ru) |
PL (1) | PL3236783T3 (ru) |
RU (1) | RU2706072C2 (ru) |
SA (1) | SA517381762B1 (ru) |
SG (1) | SG11201704399RA (ru) |
TW (1) | TWI693893B (ru) |
WO (1) | WO2016102316A1 (ru) |
ZA (1) | ZA201704821B (ru) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11622952B2 (en) | 2017-08-15 | 2023-04-11 | Evonik Operations Gmbh | Tablets with high active ingredient content of omega-3 fatty acid amino acid salts |
WO2019093708A1 (ko) * | 2017-11-08 | 2019-05-16 | 김승수 | 악취 억제형 불포화오일 및 아르기닌 함유 조성물의 제조 방법 |
US20220280388A1 (en) | 2019-08-08 | 2022-09-08 | Evonik Operations Gmbh | Method of preparing a solid dosage form and a binder |
EP4009961A1 (en) | 2019-08-08 | 2022-06-15 | Evonik Operations GmbH | Solubility enhancement of poorly soluble actives |
EP3804699A1 (en) | 2019-10-10 | 2021-04-14 | Evonik Operations GmbH | Method of preparing a solid dosage form and a binder |
CA3146612A1 (en) * | 2019-08-08 | 2021-02-11 | Evonik Operations Gmbh | Down streaming process for the production of polyunsaturated fatty acid salts |
KR20220044543A (ko) | 2019-08-08 | 2022-04-08 | 에보니크 오퍼레이션즈 게엠베하 | 고체 투여 형태를 제조하는 방법 및 윤활제 |
IL294990A (en) * | 2020-01-30 | 2022-09-01 | Silicycle Inc | A process for preparing a solid form of basic amino acid salts of polyunsaturated fatty acids |
EP4125437A1 (en) | 2020-04-01 | 2023-02-08 | Evonik Operations GmbH | Preparation for use as vasorelaxant |
US20230149336A1 (en) | 2020-04-01 | 2023-05-18 | Evonik Operations Gmbh | Preparation for use as antioxidant |
CN111635306B (zh) * | 2020-06-12 | 2022-09-27 | 上海海益环保科技有限公司 | 一种芥酸复合稳定剂及制备稳定芥酸的方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1264987B1 (it) * | 1993-12-14 | 1996-10-17 | Prospa Bv | Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono |
KR101045035B1 (ko) * | 2002-11-22 | 2011-06-30 | 니폰스이산가부시키가이샤 | 산화 안정성이 향상된 이중결합을 가진 유기물을 함유하는조성물 |
EP1637134A4 (en) * | 2003-06-20 | 2010-01-27 | Mochida Pharm Co Ltd | COMPOSITION FOR THE PREVENTION AND TREATMENT OF VARICES |
ATE453332T1 (de) * | 2005-02-02 | 2010-01-15 | Dsm Ip Assets Bv | Pulverzusammensetzungen |
US20140199313A1 (en) * | 2005-03-02 | 2014-07-17 | Metanomics Gmbh | Process for the Production of Fine Chemicals |
KR20170042364A (ko) * | 2006-06-05 | 2017-04-18 | 디에스엠 뉴트리셔널 프라덕츠 아게 | 개선된 쉘을 가지는 마이크로캡슐 |
WO2008003064A2 (en) * | 2006-06-29 | 2008-01-03 | Martek Biosciences Corporation | Sweetened oil compositions and methods of making |
CA2704345C (en) * | 2007-11-01 | 2016-07-26 | Enzymotec Ltd. | Lipid mixture for infant nutrition |
CA2803558C (en) * | 2010-06-30 | 2018-05-29 | Mochida Pharmaceutical Co., Ltd. | .omega.3 fatty acid compound preparation |
-
2015
- 2015-12-17 CA CA2969157A patent/CA2969157A1/en active Granted
- 2015-12-17 JP JP2017533761A patent/JP6714000B2/ja active Active
- 2015-12-17 PE PE2017001086A patent/PE20171082A1/es unknown
- 2015-12-17 MX MX2017008274A patent/MX2017008274A/es unknown
- 2015-12-17 ES ES15820481T patent/ES2776393T3/es active Active
- 2015-12-17 RU RU2017125963A patent/RU2706072C2/ru active
- 2015-12-17 PL PL15820481T patent/PL3236783T3/pl unknown
- 2015-12-17 NZ NZ732380A patent/NZ732380A/en unknown
- 2015-12-17 SG SG11201704399RA patent/SG11201704399RA/en unknown
- 2015-12-17 AU AU2015371457A patent/AU2015371457B2/en active Active
- 2015-12-17 KR KR1020177016895A patent/KR20170094789A/ko not_active Application Discontinuation
- 2015-12-17 BR BR112017013445-4A patent/BR112017013445B1/pt active IP Right Grant
- 2015-12-17 US US15/538,719 patent/US20170367394A1/en not_active Abandoned
- 2015-12-17 DK DK15820481.8T patent/DK3236783T3/da active
- 2015-12-17 WO PCT/EP2015/080293 patent/WO2016102316A1/en active Application Filing
- 2015-12-17 CN CN201580070558.XA patent/CN107105693B/zh active Active
- 2015-12-17 EP EP15820481.8A patent/EP3236783B1/en active Active
- 2015-12-17 MY MYPI2017702257A patent/MY190506A/en unknown
- 2015-12-18 TW TW104142797A patent/TWI693893B/zh active
-
2017
- 2017-05-24 IL IL252482A patent/IL252482B/en unknown
- 2017-06-14 CO CONC2017/0005849A patent/CO2017005849A2/es unknown
- 2017-06-18 SA SA517381762A patent/SA517381762B1/ar unknown
- 2017-06-19 PH PH12017501144A patent/PH12017501144A1/en unknown
- 2017-06-19 CL CL2017001613A patent/CL2017001613A1/es unknown
- 2017-07-17 ZA ZA2017/04821A patent/ZA201704821B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2017125962A (ru) | Способ повышения устойчивости композиции, содержащей омега-3 полиненасыщенные жирные кислоты | |
RU2017125963A (ru) | Способ повышения устойчивости композиции, содержащей омега-6 полиненасыщенные жирные кислоты | |
HRP20201250T1 (hr) | Topikalni pripravci koji sadrže kortikosteroid i retinoid namijenjeni liječenju psorijaze | |
JP2018526325A5 (ru) | ||
RU2014118120A (ru) | Привлекательный корм для домашних животных и способы улучшения привлекательности корма для домашних животных | |
CA3010992A1 (en) | Treatment of surface-reacted calcium carbonate | |
HRP20211437T1 (hr) | Pripravak insekticida/miticida na bazi soli masnih kiselina | |
RU2016128374A (ru) | Усилитель вкусовой привлекательности корма для животных, способ его получения и применение | |
WO2015011120A3 (en) | Salts of dasatinib in crystalline form | |
WO2012171001A3 (en) | Food products containing beta-glucans and omega-3 fatty acids | |
WO2016137825A8 (en) | Millicapsule formulations comprising polyunsaturated free fatty acids | |
MX2018007610A (es) | Composiciones activas suavizantes de tejidos. | |
WO2012112841A3 (en) | [1,2,4]oxadiazol-3-yl acid salts and crystalline forms and their preparation | |
MX2014008494A (es) | Emulsion oragnica que comprende dha y epa. | |
ATE549943T1 (de) | Verfahren zur herstellung von sojasaucenpulver | |
MY192364A (en) | Compositions of mixed diesters of 1,4:3-6-dianhydrohexitol | |
ES2527366A1 (es) | Composición detergente que comprende un biosurfactante de origen vegetal | |
FI20166034A (fi) | Polttoainekoostumuksen valmistaminen | |
TH1701005258A (th) | วิธีการสำหรับผลิตกรดฟูแรน-2,5-ไดคาร์บอกซิลิค (fdca) จากสารละลายเกลือ | |
TH1701005257A (th) | วิธีการสำหรับผลิตกรดฟูแรน-2,5-ไดคาร์บอกซิลิค (fdca) จากเกลือของแข็ง | |
TH168845A (th) | สารองค์ประกอบไขน้ำมันสำหรับแป้งนวดของจำพวกเส้นบะหมี่และไขน้ำมันสำหรับ แป้งนวดของจำพวกเส้นบะหมี่และวิธีผลิตจำพวกเส้นบะหมี่ | |
TH160005B (th) | เชื้อเพลิงดีเซลเติมสารอิมัลซิไฟเออร์ที่มีค่าซีเทนสูง โดยมีกรดไขมันอิสระเป็นองค์ประกอบหลัก | |
PH12017502402A1 (en) | Palm oil-based wax composition, encaustic medium derived therefrom and method for producing the same | |
TH175848A (th) | สารอาหารสำหรับทารกซึ่งมีโปรตีนที่ถูกไฮโดรไลซ์ ไอออนิกแคลเซียม และกรดพาลมิติก | |
TH176863B (th) | สารอาหารสำหรับทารกซึ่งมีโปรตีนที่ถูกไฮโดรไลซ์และกรดพาลมิติก |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PD4A | Correction of name of patent owner |